Key Updates, Including ePV, for Managing Sepsis and Septic Shock
- ICU Events
- 20/03/2024
Key Updates, Including ePV, for Managing Sepsis and Septic Shock
READ MOREKey Updates, Including ePV, for Managing Sepsis and Septic Shock
READ MOREIn 2017, an estimated 25 million children worldwide experienced sepsis, resulting in over 3 million deaths. Paediatric sepsis survivors often face...
READ MORESepsis is a leading cause of hospital deaths. Despite initiatives like the Surviving Sepsis Campaign and Centers for Medicare & Medicaid Services...
READ MORESepsis is a prominent cause of mortality in ICUs. Despite extensive research on the dynamics leading to sepsis, the role of cytokines—immune system...
READ MOREThis study focuses on the impact of sepsis, a condition resulting from a dysregulated immune response to infection, on the ability of patients to...
READ MOREIntensive care impacts more than the patient, with ripple effects for families, employers and wider societies. Patient-centred outcomes reiterate the need for clinical therapies targeting the biological circuitry of the big-hitting syndromes like ARDS, sepsis, delirium, renal failure and recognising they persist beyond the veil of discharge....
READ MOREAn overview of vasopressor management, current evidence on its use, when to initiate vasopressor therapy for best possible patient outcome and a discussion regarding the use of landiolol in septic patients with persistent tachycardia. Optimising Vasopressin Initiation in Septic Shock Patients with septic shock, and especially...
READ MORESepsis can have potentially life-threatening consequences. Early recognition is crucial for effective intervention. The role of patients in preventing...
READ MORESepsis is a life-threatening condition caused by a dysregulated host response to infection. Despite progress in understanding its underlying mechanisms
READ MOREFapon, LASCCO, Abionic Formed Strategic Collaboration for PSP Sepsis Diagnosis in China
READ MORE